Clinical Trial

Cost Effectiveness in Alveolar Bone Grafting in Patients With Cleft Lip and Palate

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this trial is to evaluate if the use of Bone Morphogenic Protein(BMP)/Demineralized Bone Matrix (DBM) versus the use of autologous Iliac Crest Bone Graft (ICBG) will result in an increase in total cost effectiveness for patients undergoing alveolar bone graft (ABG) for Cleft Lip and Palate (CLP) and to see if patients who are treated with DBM/BMP will have reduced post-operative pain scores,reduced operative times,and similar rates of bone healing compared to conventional ICBG.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2020-01-15; most recent amendment 2026-02-17.
Status change: Not Yet Recruiting → Recruiting 2021-10-05
Trial Details
NCT Number NCT04234971
Lead Sponsor The University of Texas Health Science Center, Houston
Conditions Cleft Lip and Palate
Enrollment 40 participants
Start Date 2021-06-14
Primary Completion 2028-01-01 (estimated)
Study Completion 2028-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-19